Tag
Hexagon Nutrition Limited
9 articles
Hexagon Nutrition concluded fiscal year 2026 with revenue growth and profitability, recently approving audited financial results and completing an IPO through an Offer for Sale. While the company has successfully listed on the NSE and BSE, auditors have flagged material uncertainty regarding the going concern of two foreign subsidiaries due to net liability positions, a factor investors should monitor. Furthermore, the company disclosed that Joint Managing Director Dr. Nikhil Kelkar holds New Zealand citizenship, though he remains an Indian resident for tax purposes. These developments highlight both the growth potential and ongoing risks associated with Hexagon Nutrition's international operations.
Hexagon Nutrition Q4 FY26 Earnings Call Recording Available
Hexagon Nutrition disclosed availability of audio recording for its Q4 FY26 earnings conference call held on July 17, 2026.
The call discussed audited standalone and consolidated financial results for
Hexagon Nutrition Q4 FY26 PAT Surges 56% to ₹379M
Hexagon Nutrition Limited disclosed its Q4 FY26 investor presentation, reporting a 56% YoY PAT growth to ₹379 million with margins expanding significantly.
Revenue reached ₹3,826 million, driven by gr
Hexagon Nutrition Schedules FY26 Earnings Conference Call
Hexagon Nutrition will hold an analyst/investor call on July 17, 2026, to discuss audited FY26 results.
The meeting will feature MD Vikram Kelkar, Jt MD Nikhil Kelkar, and CFO Soman Jana.
The company
Hexagon Nutrition Maiden Earnings Call July 17
Hexagon Nutrition schedules its maiden earnings conference call for July 17, 2026, to discuss FY26 audited results.
Management participants include MD Vikram Kelkar, Jt MD Nikhil Kelkar, and CFO Soman
Hexagon Nutrition Maiden FY26 Earnings Conference Call
Hexagon Nutrition will hold its maiden conference call on July 17, 2026, to discuss audited FY26 results.
Management participants include MD Vikram Kelkar, Jt MD Nikhil Kelkar, and CFO Soman Jana.
The
Hexagon Nutrition Approves FY26 Audited Results
Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Re-appointed KPMSS & Associates as Cost Auditor and Bhuwania & Agrawal Associates as
Hexagon Nutrition Approves FY26 Results, Reappoints Auditors
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026.
Reappointed KPMSS & Associates as Cost Auditor and Bhuwania & Agrawal as Internal Auditor for F
Hexagon Nutrition FY26 Results and Board Decisions
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, showing revenue growth and profitability.
Re-appointed KPMSS & Associates as Cost Auditor and B
Hexagon Nutrition Board Approves FY26 Results, Reappoints Auditors
Hexagon Nutrition's board approved audited standalone and consolidated financial results for Q1 and full year ended March 31, 2026.
The board reappointed KPMSS & Associates as Cost Auditor and Bhuwani